Affiliation:
1. State Research Centre for Preventive Medicine, Moscow
Abstract
The paper discusses the social and economic costs associated with diabetes mellitus (DM) and its complications. Cardiovascular disease (CVD) is the leading cause of disability and complications in DM patients. The diagnostics and correction of the early disturbances of carbohydrate metabolism are important components of the primary prevention of Type 2 DM (DM-2). The DM-2 development is preceded by the abnormalities typically overlooked by the busy practitioners, such as impaired fasting glucose and impaired glucose tolerance. The authors present the evidence from international clinical trials confirming that the early disturbances of carbohydrate metabolism are an independent risk factor of CVD. Therefore, recently, the importance of the combined primary prevention of DM-2 and diabetes-associated CVD has been extensively discussed.
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Fact sheets Media centre WHO. http://www.who.int/mediacentre/ factsheets/fs317/ru/Russian (Byulleten' Tsentra SMIVOZ http://www. who.int/mediacentre/factsheets/fs317/ru/).
2. Mareev VU. Councils to the practising doctor — importance of a timely assessment of risk factors. http://www.medikalsite.ru Russian (Mareev V. Yu. Sovety praktikuyushchemu vrachu — vazhnost' svoevre- mennoi otsenki faktorov riska http://www.medikalsite.ru).
3. Vertkina AL. The scientific journal district therapist http://www.medikalsite. ru Russian (Vertkina A. L. Nauchnyi meditsinskii zhurnal «Uchastkovyi terapevt», http://www.medikalsite.ru).
4. Suntsov YI, Dedov II, Kudryakova SV. State Register of diabetes: epidemiological characteristics of type 2 diabetes. Journal “Diabetes” http://www.novo.ru/Sdiabet/1998/regis.htm Russian (Suntsov Yu. I., Dedov I. I., Kudryakova S. V. Gosudarstvennyi registr sakharnogo diabeta: epidemiologicheskaya kharakteristika insudin-nezavisi- mogo sakharnogo diabeta. Zh Sakharnyi diabet http://www.novo.ru/ Sdiabet/1998/regis.htm).
5. Jönsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002; 45 (7): 5–12, 21.